Efficient assessment of drug safety and toxicity can be a complex and time-consuming matter. We develop and deliver integrated cardiovascular services to enhance the assessment of cardiac safety and toxicity of drug candidates.

Learn more about our Safety Services

Learn more about CiPA


We combine our cardiovascular knowledge with expertise in hiPSC-derived cardiomyocyte manufacturing to offer you predictive and translational in vitro disease models, as well as assays for efficacy screening at any throughput.

Learn more about our Efficacy services

Our products

Ncardia's hiPSC products portfolio encompasses a broad panel of cardiovascular and neural cells. In addition, the company delivers the Cardioplate™ product line of quality-controlled ready-to-use assay plates.

Cardiac cells
Neural cells

Meet the team

Ncardia is committed to delivering working assays solutions through in-house assay development and customized support. Do not hesitate to contact our team for more information.

News & Events

Below is a selection of our latest news, and the events where you can meet us.


Be inspired by a selection of our latest innovations.